Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Chimeric anti-factor D MAb from Tanox for complement-mediated disorders

Sep. 21, 1999

Ischemia-selective mechanism implicated in the antiarrhythmic activity of PAF antagonist

Sep. 20, 1999

AstraZeneca seeks FDA approval of Toprol-XL as heart failure treatment

Sep. 17, 1999

K(ATP) channel opener with improved cardioprotective efficacy designed at BMS

Sep. 16, 1999

BASF's new ET antagonists described in patent literature

Sep. 16, 1999

Cypros receives additional notice of allowance concerning U.S. patent on Cordox

Sep. 16, 1999

Modulators of cGMP production in development at HMR

Sep. 15, 1999

BiDil combination therapy offers benefits for black CHF patients

Sep. 15, 1999

Promising data on Resten-NG presented at international cardiology conference

Sep. 15, 1999

Endothelin antagonists described by BMS for hypertension, etc.

Sep. 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...